PBYI

Puma Biotechnology Stock Analysis

AI Rating

Great
  • Quality8/10
  • Growth↑ 7/10
  • Momentum↑ 9/10
Puma Biotechnology sales and earnings growth
PBYI Growth
Good
  • Revenue Y/Y↓ -12.96%
  • EPS Y/Y↑ 56.25%
  • FCF Y/Y↑ 27.27%
Puma Biotechnology gross and profit margin trends
PBYI Profitability
Neutral
  • Gross margin ↑ 76.90%
  • EPS margin↑ 17.40%
  • ROIC↑ 61.40%
Puma Biotechnology net debt vs free cash flow
PBYI Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↓ 0.0
  • Interest coverage↓ 4.8

Puma Biotechnology stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗